TAG Therapeutics
TAG Therapeutics is a Healthcare & Life Sciences startup based in Austria, most recent round Series A, 1 tracked investor.
About TAG Therapeutics
TAG Therapeutics is a company headquartered in Austria. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops TELOBLOCK, an antisense nucleotide therapy that inhibits the DNA damage response specifically at short or damaged telomeres to prevent telomere-induced cellular senescence; active in preclinical models for telomere biology disorders (e.g., pulmonary fibrosis, bone marrow failure) and ex-vivo enhancement of hematopoietic cells.
Explore TAG Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.